Table 2 Patient and lesion characteristics before PDT
radiation dose (Gy) | concomitant chemotherapeutic regimen | pattern of failure | number of lesion | histological confirmation | tumor length (cm) | lesion circumference of the lumen | clinical stage | |
|---|---|---|---|---|---|---|---|---|
Level 1 (50 J/cm2) | ||||||||
No.1 | 60 | cisplatin + 5FU | residue | 1 | positive | 2.0 | <1/4 | T2N0M0 |
No.2 | 60 | nedaplatin + 5FU | recurrence | 1 | positive | 1.0 | <1/4 | T1N0M0 |
No.3 | 60 | 5FU | residue | 1 | negative | 1.5 | <1/4 | T2N0M0 |
Level 2 (75 J/cm2) | ||||||||
No.4 | 60 | cisplatin + 5FU | recurrence | 1 | positive | 1.0 | <1/4 | T1N0M0 |
No.5 | 60 | - | recurrence | 1 | positive | 0.8 | <1/4 | T1N0M0 |
No.6 | 60 | - | recurrence | 1 | positive | 2.0 | 1/4-1/2 | T1N0M0 |
Level 3 (100 J/cm2) | ||||||||
No.7 | 60 | cisplatin + 5FU | recurrence | 1 | positive | 1.0 | 1/4-1/2 | T1N0M0 |
No.8 | 50.4 | cisplatin + 5FU | recurrence | 1 | positive | 3.0 | <1/4 | T2N0M0 |
No.9 | 70 | cisplatin + 5FU | recurrence | 1 | positive | 1.0 | <1/4 | T1N0M0 |